- Home
- WKC vs SVRA Comparison
WKC vs SVRA Comparison
Compare WKC & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WKC | SVRA |
|---|---|---|
| Founded | 1984 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WKC | SVRA |
|---|---|---|
| Price | $24.39 | $6.63 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $28.75 | $6.88 |
| AVG Volume (30 Days) | 743.5K | ★ 3.2M |
| Earning Date | 10-23-2025 | 11-12-2025 |
| Dividend Yield | ★ 3.30% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $37,648,100,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.13 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.71 | $1.89 |
| 52 Week High | $31.54 | $7.01 |
Technical Indicators
Market Signals| Indicator | WKC | SVRA |
|---|---|---|
| Relative Strength Index (RSI) | 53.50 | 70.55 |
| Support Level | $23.78 | $5.55 |
| Resistance Level | $24.36 | $7.01 |
| Average True Range (ATR) | 0.54 | 0.46 |
| MACD | 0.15 | 0.05 |
| Stochastic Oscillator | 81.42 | 79.11 |
Price Performance
Historical ComparisonAbout WKC World Kinect Corporation
World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.